AstraZeneca released full results from two successful late-stage trials on its experimental drug for chronic obstructive pulmonary disease. The detailed data reinforces hopes that the product could be ...
Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. In a pair of late-stage trials, a ...
Many patients with chronic obstructive pulmonary disease (COPD) have exacerbations despite receiving standard-of-care inhaled maintenance therapy. Dysregulated interleukin-33 signaling is implicated ...
COPD puts people at risk for many other adverse health conditions. AndreyPopov/iStock via Getty Images Plus Chronic obstructive pulmonary disease, or COPD, caused 141,733 deaths in the United States ...
On April 1, the National Council Licensure Examination for registered nurses will include more competencies in care management and basic care and comfort, while most of the exam structure, scoring and ...
It’s a simple question that physicians usually do not ask their patients: “When was your last drink?” “If the patient says yesterday, you know the patient isn’t a casual drinker,” said Joe G. Zein, MD ...
Dedicated COPD respiratory therapists can improve inhaler use, ensure adherence, and bridge care transitions, explained Megan Dulohery Scrodin, MD. Among the common pitfalls of chronic obstructive ...
The National Council Licensure Examination, or NCLEX, averaged an 87.8% passage rate in 2023, according to the National Council of State Boards of Nursing. The council surveyed more than 2,000 nursing ...
Chronic obstructive pulmonary disease, or COPD, is the fourth leading cause of death worldwide, responsible for 3.5 million deaths in 2021, according to the World Health Organization. It’s a common ...
Chronic obstructive pulmonary disease and cardiovascular diseases are among the leading chronic health burdens worldwide. They share key modifiable risk factors as well as overlapping ...
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially ...
A new study shows that a form of vitamin B3 can reduce lung inflammation in COPD patients. The researchers hope it will pave the way for new treatment options. We live longer and longer, and as we age ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results